focus -WSS

focus

author：focus 2025-08-12 09:09:33 - browse：5

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Palantir health business leans on meeting customers’ needs

WSS

IRA could hurt research into orphan drugs for rare diseases

It's time to get medical device identifiers over the finish line

Will the IRA bring competition to the biologics market?

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

A common UTI test for kids haunts adults as a traumatic 'nightmare'

knowledge

focus

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA proposes changes to key medical devices approval pathway

What does generative AI mean for health care? We asked experts

Long Covid needs a new name — and a new frame

New air purifier tech could be key to improving indoor air quality

Beach reads and more: STAT's 2023 summer book list

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Elizabeth Holmes on track for early release from her 11

In Memoriam: Notable people who died in 2023

Walmart eyes Medicare Advantage provider ChenMed

Wikipedia

Palantir health business leans on meeting customers’ needs

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

WATCH: Why do bright lights make us see spots?

Lecanemab for Alzheimer's is coming. Is the health system ready?

HCA discloses massive data breach affecting 11 million patients

IRA could hurt research into orphan drugs for rare diseases

leisure time

hotspot

entertainment

focus